Anemia of chronic diseases
- 13 May 2024
- journal article
- review article
- Published by Alfmed LLC in Medical alphabet
- No. 13,p. 14-20
Abstract
Anemia of chronic diseases is one of the most common diseases and has a significant impact on prognosis and mortality. The article discusses the relevance, pathogenesis, clinical manifestations, laboratory diagnostics, and treatment of anemia of chronic diseases. The treatment of anemia depends on the severity and the disease of which it is a complication. Anemia is considered in oncological diseases, chronic kidney disease, chronic heart failure, cirrhosis of the liver, celiac disease, etc. Therapy aimed at replenishing iron deficiency includes transfusion of erythrocyte mass, erythropoietin stimulants, iron-containing drugs. According to the literature review, information is provided on the peculiarities of managing patients with anemia in various chronic diseases, an overview of the modern approach to ferrotherapy and its complications is given. Information is provided on a new form of oral iron – Sucrosomal iron (SiderAL Forte), which is well tolerated and has high bioavailability. A review of clinical studies confirming the efficacy and safety of oral Sucrosomal iron is presented.Keywords
This publication has 23 references indexed in Scilit:
- Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non‐randomized, open‐label, proof‐of‐concept studyEuropean Journal of Heart Failure, 2021
- Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron DeficiencyJAMA, 2017
- Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot studySupportive Care in Cancer, 2017
- Management of anemia in patients with congestive heart failureAmerican Journal of Hematology, 2016
- P530 Comparison between liposomial iron and ferrous sulfate in patients with iron deficiency anemia and inflammatory bowel disease. A pilot controlled studyJournal of Crohn's and Colitis, 2014
- Anemia of chronic disease: A unique defect of iron recycling for many different chronic diseasesEuropean Journal of Internal Medicine, 2014
- Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammationAmerican Journal of Hematology, 2011
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney DiseaseNew England Journal of Medicine, 2009
- Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal diseaseKidney International, 2009
- Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion ProteinNew England Journal of Medicine, 1997